219 related articles for article (PubMed ID: 16831916)
1. Direct and indirect estrogen actions on osteoblasts and osteoclasts.
Zallone A
Ann N Y Acad Sci; 2006 Apr; 1068():173-9. PubMed ID: 16831916
[TBL] [Abstract][Full Text] [Related]
2. IL-1 alpha stimulates the formation of osteoclast-like cells by increasing M-CSF and PGE2 production and decreasing OPG production by osteoblasts.
Tanabe N; Maeno M; Suzuki N; Fujisaki K; Tanaka H; Ogiso B; Ito K
Life Sci; 2005 Jun; 77(6):615-26. PubMed ID: 15921993
[TBL] [Abstract][Full Text] [Related]
3. Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG/RANKL/RANK system.
Liu XH; Kirschenbaum A; Yao S; Levine AC
Ann N Y Acad Sci; 2006 Apr; 1068():225-33. PubMed ID: 16831922
[TBL] [Abstract][Full Text] [Related]
4. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
Seriwatanachai D; Thongchote K; Charoenphandhu N; Pandaranandaka J; Tudpor K; Teerapornpuntakit J; Suthiphongchai T; Krishnamra N
Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
[TBL] [Abstract][Full Text] [Related]
5. Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts.
Imai Y; Youn MY; Kondoh S; Nakamura T; Kouzmenko A; Matsumoto T; Takada I; Takaoka K; Kato S
Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E31-9. PubMed ID: 19751412
[TBL] [Abstract][Full Text] [Related]
6. The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease.
Brunetti G; Colucci S; Rizzi R; Mori G; Colaianni G; Oranger A; Zallone A; Liso V; Grano M
Ann N Y Acad Sci; 2006 Apr; 1068():334-40. PubMed ID: 16831934
[TBL] [Abstract][Full Text] [Related]
7. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
[TBL] [Abstract][Full Text] [Related]
8. Alteration of bone cell function by RANKL and OPG in different in vitro models.
Lin JM; Callon KE; Lin CQ; Bava U; Zheng MH; Reid IR; Cornish J
Eur J Clin Invest; 2007 May; 37(5):407-15. PubMed ID: 17461987
[TBL] [Abstract][Full Text] [Related]
9. [Recent advances in the regulation of bone remodeling].
Matsumoto T
Nihon Rinsho; 2004 Feb; 62 Suppl 2():37-46. PubMed ID: 15035093
[No Abstract] [Full Text] [Related]
10. [Regulatory mechanism of osteoclast differentiation and function].
Okumura S; Udagawa N; Takahashi N
Nihon Rinsho; 2004 Feb; 62 Suppl 2():90-6. PubMed ID: 15035103
[No Abstract] [Full Text] [Related]
11. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; Rédini F
Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor family receptors regulating bone turnover: new observations in osteoblastic and osteoclastic cell lines.
Robinson LJ; Borysenko CW; Blair HC
Ann N Y Acad Sci; 2007 Nov; 1116():432-43. PubMed ID: 17646260
[TBL] [Abstract][Full Text] [Related]
13. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Measurement and clinical role of OPG].
Sasaki N; Kusano E
Clin Calcium; 2006 Jun; 16(6):956-62. PubMed ID: 16751691
[TBL] [Abstract][Full Text] [Related]
14. The effect of sex hormones on bone metabolism of the otic capsule--an overview.
Horner KC
Hear Res; 2009 Jun; 252(1-2):56-60. PubMed ID: 19121641
[TBL] [Abstract][Full Text] [Related]
15. [Role of tumor necrosis factor family ligands in the pathogenesis of rheumatoid arthritis--new therapeutical opportunities].
Kmieć Z; Sokołowska I
Pol Merkur Lekarski; 2007 Apr; 22(130):300-4. PubMed ID: 17684931
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts.
Yonou H; Horiguchi Y; Ohno Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
Prostate; 2007 Jun; 67(8):840-8. PubMed ID: 17394194
[TBL] [Abstract][Full Text] [Related]
17. Mechanical regulation of osteoclastic genes in human osteoblasts.
Kreja L; Liedert A; Hasni S; Claes L; Ignatius A
Biochem Biophys Res Commun; 2008 Apr; 368(3):582-7. PubMed ID: 18243138
[TBL] [Abstract][Full Text] [Related]
18. Effect of mechanical stimulation on osteoblast- and osteoclast-like cells in vitro.
Kadow-Romacker A; Hoffmann JE; Duda G; Wildemann B; Schmidmaier G
Cells Tissues Organs; 2009; 190(2):61-8. PubMed ID: 19033679
[TBL] [Abstract][Full Text] [Related]
19. Oestrogen effects on osteoblasts and osteoclasts.
Oursler MJ; Landers JP; Riggs BL; Spelsberg TC
Ann Med; 1993 Aug; 25(4):361-71. PubMed ID: 8217102
[TBL] [Abstract][Full Text] [Related]
20. [Adhesion molecules in the context with bone remodeling and osteoporosis].
Tanaka Y
Nihon Rinsho; 2004 Feb; 62 Suppl 2():125-30. PubMed ID: 15035110
[No Abstract] [Full Text] [Related]
[Next] [New Search]
